# Botulinum for Chronic Exertional Compartment Syndrome

> **NCT03339921** · PHASE2,PHASE3 · TERMINATED · sponsor: **375th Medical Group, Scott Air Force Base** · enrollment: 3 (actual)

## Conditions studied

- Chronic Exertional Compartment Syndrome

## Interventions

- **DRUG:** Botulinum toxin injections for chronic compartment syndrome
- **PROCEDURE:** surgical fasciotomy for chronic compartment syndrome

## Key facts

- **NCT ID:** NCT03339921
- **Lead sponsor:** 375th Medical Group, Scott Air Force Base
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-07
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** This study is being closed because it is unworkable.
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339921, "Botulinum for Chronic Exertional Compartment Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03339921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*